Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-06-08Clinical Trial Update: Assessment of Paclitaxel-Induced Neuropathy
This clinical trial update concerns assessment of paclitaxel-induced neuropathy in cancer patients, including breast and ovarian cancer, and…
-
CLINICAL_TRIALS research · 2025-06-08Clinical Trial Update: O-RADS MRI System on Early Detection of Ovarian Cancer
ClinicalTrials.gov update on the O-RADS MRI system for early detection of ovarian cancer; the study is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: A Study of Hansoh (HS)-10502 in Patients With Advanced Solid Tumors [Phase 1]
A Phase 1 study evaluating Hansoh's HS-10502 in adults with advanced solid tumors, including ovarian, breast, pancreatic, prostate, and colo…
-
CLINICAL_TRIALS research · 2025-06-03Clinical Trial Update: Trial of Exercise and Lifestyle for Women With Ovarian and Endometrial Cancer [NA]
A Yale University trial is investigating exercise and lifestyle interventions for women with ovarian and endometrial cancer and is currently…
-
CLINICAL_TRIALS research · 2025-05-31Clinical Trial Update: A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors [Phase 1]
Phase 1 trial of CD70-targeted CAR-T therapy for CD70-positive advanced/metastatic solid tumors is currently recruiting, with potential indi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-05-25Clinical Trial Update: SHR - A1811 Versus Chemotherapy for Platinum-resistant Recurrent Epithelial Ovarian Cancer [Phase 3]
A Phase 3 trial comparing SHR-A1811 with chemotherapy for platinum-resistant recurrent epithelial ovarian cancer is currently not yet recrui…
-
CLINICAL_TRIALS research · 2025-05-25Clinical Trial Update: SHR - A1811 Injection in the Treatment of Platinum-sensitive Recurrent Ovarian Cancer [Phase 1, Phase 2]
A Phase 1/2 study of SHR-A1811 Injection for platinum-sensitive recurrent ovarian cancer is listed, with the trial status not yet recruiting…
-
CLINICAL_TRIALS research · 2025-05-23Clinical Trial Update: Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC [Phase 1, Phase 2]
Status update on ONC-392 showing safety, pharmacokinetics, and preliminary efficacy in monotherapy and in combination with anti-PD-1 across …
-
CLINICAL_TRIALS research · 2025-05-23Clinical Trial Update: PARP-inhibition and CTLA-4 Blockade in BRCA-deficient Ovarian Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating a PARP inhibitor combined with a CTLA-4 blocker in BRCA-deficient ovarian cancer, including fallopian tu…
-
CLINICAL_TRIALS research · 2025-05-23Clinical Trial Update: Study of Pembrolizumab Combination With Chemotherapy in Platinum-sensitive Recurrent Low-grade Serous Ovarian Cancer [Phase 2]
An ongoing Phase 2 study evaluating pembrolizumab in combination with chemotherapy for platinum-sensitive recurrent low-grade serous ovarian…
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: Testing the Addition of an Anti-cancer Drug, Elimusertib (BAY 1895344) ATR Inhibitor, to the Chemotherapy Treatment (Gemcitabine) for Advanced Pancreatic and Ovarian Cancer, and Advanced Solid Tumors [Phase 1]
A Phase 1 trial is evaluating the addition of Elimusertib, an ATR inhibitor, to gemcitabine for advanced pancreatic and ovarian cancers and …
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients With Solid Tumors [Phase 1]
This ClinicalTrials.gov update describes a Phase 1 study evaluating MNPR-101-DFO*-89Zr as a diagnostic imaging agent for adults with various…
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: COM902 (A TIGIT Inhibitor) in Subjects With Advanced Malignancies [Phase 1]
Phase 1 study of COM902, a TIGIT inhibitor, in patients with advanced malignancies is ongoing and currently not recruiting.
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: Laboratory Study of Cancer & Immune Cells in Ascites Fluid of Ovarian Cancer Patients to Test Alternative Therapies
A clinical trial update describing a laboratory study of cancer and immune cells in ascites fluid from ovarian cancer patients to test alter…
-
CLINICAL_TRIALS research · 2025-05-20Clinical Trial Update: Total Neoadjuvant 6 Cycles of Chemotherapy Versus 3 Cycles in Partial Responder Patients Diagnosed With Epithelial Ovarian Cancer [Phase 3]
Phase 3 trial evaluating total neoadjuvant chemotherapy for 6 cycles versus 3 cycles in partial responders with epithelial ovarian cancer; t…
-
CLINICAL_TRIALS research · 2025-05-18Clinical Trial Update: A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE) [NA]
A clinical trial named PRESERVE is evaluating perioperative stress reduction versus standard of care in patients with ovarian cancer and rel…
-
CLINICAL_TRIALS research · 2025-05-16Clinical Trial Update: EON: A Single-arm Phase II Study of Etigilimab (OMP-313M32) in Combination With Checkpoint Inhibition (Nivolumab) in Patients With Platinum-resistant, Recurrent Epithelial Ovarian Cancer [Phase 2]
Phase II single-arm study evaluating Etigilimab (OMP-313M32) with nivolumab in platinum-resistant, recurrent epithelial ovarian cancer; the …
-
CLINICAL_TRIALS research · 2025-05-16Clinical Trial Update: Transforming Ovarian Cancer Diagnostic Pathways
This document reports ongoing recruitment for a clinical trial aimed at transforming diagnostic pathways for ovarian cancer.
-
CLINICAL_TRIALS research · 2025-05-13Clinical Trial Update: Performance of SYMMCORA® vs. V-Loc® Suture Material in Patients Undergoing Laparoscopic Total Hysterectomy
This clinical trial update compares SYMMCORA and V-Loc barbed sutures in patients undergoing laparoscopic total hysterectomy, with recruitme…
-
CLINICAL_TRIALS research · 2025-05-06Clinical Trial Update: Tempus Priority Study: A Pan-tumor Observational Study
Tempus AI's Pan-tumor Priority Study is an observational cancer study that is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-05-06Clinical Trial Update: Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples
This clinical trial update describes a Stanford-sponsored study investigating BRCA1/BRCA2-associated tumors and the collection of related tu…
-
CLINICAL_TRIALS research · 2025-05-04Clinical Trial Update: Niraparib and Neratinib in Advanced Solid Tumors With Expansion Cohort in Advanced Ovarian Cancer [Phase 1]
Phase 1 clinical trial update evaluating the combination of niraparib and neratinib in advanced solid tumors with an expansion cohort in ova…
-
CLINICAL_TRIALS research · 2025-05-01Clinical Trial Update: A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating AMXI-5001 in patients with advanced cancers, including breast, ovarian, prostate, and pancreatic cance…
-
CLINICAL_TRIALS research · 2025-04-30Clinical Trial Update: IN10018 in Combination With Pegylated Liposomal Doxorubicin (PLD) vs. Placebo in Combination With PLD for the Treatment of Platinum-resistant Recurrent Ovarian Cancer [Phase 2]
A Phase 2 trial evaluating IN10018 in combination with pegylated liposomal doxorubicin versus PLD with placebo in platinum-resistant recurre…
-
CLINICAL_TRIALS research · 2025-04-30Clinical Trial Update: IN10018 in Combination With Standard Chemotherapy in High-grade Serous Epithelial Ovarian Cancer [Phase 1, Phase 2]
A Phase 1/2 trial (IN10018) evaluating IN10018 in combination with standard chemotherapy for high-grade serous epithelial ovarian cancer is …